American Association for Cancer Research
Browse

Table S1 from A Phenogenetic Axis that Modulates Clinical Manifestation and Predicts Treatment Outcome in Primary Myeloid Neoplasms

Download (18.2 kB)
dataset
posted on 2023-04-04, 01:25 authored by Qiujin Shen, Yahui Feng, Xiaowen Gong, Yujiao Jia, Qingyan Gao, Xiaokang Jiao, Saibing Qi, Xueou Liu, Hui Wei, Bingqing Huang, Ningning Zhao, Xiaoqiang Song, Yueshen Ma, Shihao Liang, Donglei Zhang, Li Qin, Ying Wang, Shiqiang Qu, Yao Zou, Yumei Chen, Ye Guo, Shuhua Yi, Gang An, Zengtao Jiao, Song Zhang, Linfeng Li, Jun Yan, Huijun Wang, Zhen Song, Yingchang Mi, Lugui Qiu, Xiaofan Zhu, Jianxiang Wang, Zhijian Xiao, Junren Chen

Table S1. Clinicopathologic characteristics of the 730 myeloid neoplasm patients in THAMP.

Funding

Tianjin Science and Technology Plan

Chinese Academy of Medical Sciences (CAMS)

State Key Laboratory of Experimental Hematology (SKLEH)

History

ARTICLE ABSTRACT

The current criteria for disease diagnosis treat myeloid neoplasms as a group of distinct, separate diseases. This work provides genomics evidence for a “myeloid neoplasm continuum” and suggests that boundaries between myeloid neoplastic diseases are much more blurred than previously thought.